Multivalent nanoparticle networks enable point-of-care detection of human phospholipase-A2 in serum

ACS Nano

Volumn 9, Issue 3, 2015, Pages 2565-2573

  Chapman, Robert ^a   Lin, Yiyang ^a   Burnapp, Mark ^b   Bentham, Andrew ^b   Hillier, David ^c   Zabron, Abigail ^c   Khan, Shahid ^c   Tyreman, Matthew ^b   Stevens, Molly M ^a  

^a IMPERIAL COLLEGE LONDON   (United Kingdom)

^b Mologic Ltd   (United Kingdom)

^c ST MARY S HOSPITAL   (United Kingdom)

Author keywords

biosensor; lateral flow device; multivalent network; phospholipase; point of care

Indexed keywords

ADHESION; BIOSENSORS; ENZYME ACTIVITY; EYE PROTECTION; GOLD COATINGS; METAL NANOPARTICLES; PLASMONS; SURFACE PLASMON RESONANCE;

ENZYME SUBSTRATES; LATERAL FLOW; LATERAL FLOW ASSAY; LOCALIZED SURFACE PLASMON RESONANCE; NAKED-EYE DETECTION; NANOPARTICLE NETWORKS; PHOSPHOLIPASES; POINT OF CARE;

GOLD NANOPARTICLES;

BIOTIN; LIPOSOME; MACROGOL DERIVATIVE; NANOPARTICLE; PHOSPHOLIPASE A2;

ACUTE DISEASE; ANIMAL; BLOOD; BLOOD ANALYSIS; CHEMICAL STRUCTURE; CHEMISTRY; ELAPIDAE; ENZYMOLOGY; FEMALE; HOSPITAL INFORMATION SYSTEM; HUMAN; MALE; METABOLISM; NANOTECHNOLOGY; PANCREATITIS; PROCEDURES; PROTEIN CONFORMATION;

ACUTE DISEASE; ANIMALS; BIOTIN; BLOOD CHEMICAL ANALYSIS; ELAPIDAE; FEMALE; HUMANS; LIPOSOMES; MALE; MODELS, MOLECULAR; NANOPARTICLES; NANOTECHNOLOGY; PANCREATITIS; PHOSPHOLIPASES A2; POINT-OF-CARE SYSTEMS; POLYETHYLENE GLYCOLS; PROTEIN CONFORMATION;

EID: 84925633500     PISSN: 19360851     EISSN: 1936086X     Source Type: Journal    
DOI: 10.1021/nn5057595     Document Type: Article

References (44)

1. Cirino, G. Multiple Controls in Inflammation-Extracellular and Intracellular Phospholipase A2, Inducible and Constitutive Cyclooxygenase, and Inducible Nitric Oxide Synthase Biochem. Pharmacol. 1998, 55, 105-111
2. Dennis, E. A. Diversity of Group Types, Regulation, and Function of Phospholipase A2 J. Biol. Chem. 1994, 269, 13057-13060
3. Kugiyama, K.; Ota, Y.; Takazoe, K.; Moriyama, Y.; Kawano, H.; Miyao, Y.; Sakamoto, T.; Soejima, H.; Ogawa, H.; Doi, H. et al. Circulating Levels of Secretory Type II Phospholipase A2 Predict Coronary Events in Patients with Coronary Artery Disease Circulation 1999, 100, 1280-1284
4. Eskola, J. U.; Nevalainen, T. J.; Kortesuo, P. Immunoreactive Pancreatic Phospholipase A2 and Catalytically Active Phospholipases A2 in Serum from Patients with Acute Pancreatitis Clin. Chem. 1988, 34, 1052-1054
5. Schrama, A. J. J.; de Beaufort, A. J.; Poorthuis, B. J. H. M.; Berger, H. M.; Walther, F. J. Secretory Phospholipase A2 in Newborn Infants with Sepsis J. Perinatol. 2008, 28, 291-296
6. Menschikowski, M.; Hagelgans, A.; Fuessel, S.; Mareninova, O. A.; Neumeister, V.; Wirth, M. P.; Siegert, G. Serum Levels of Secreted Group Iia Phospholipase A2 in Benign Prostatic Hyperplasia and Prostate Cancer: A Biomarker for Inflammation or Neoplasia? Inflammation 2012, 35, 1113-1118
7. Dong, Z.; Liu, Y.; Scott, K. F.; Levin, L.; Gaitonde, K.; Bracken, R. B.; Burke, B.; Zhai, Q. J.; Wang, J.; Oleksowicz, L. et al. Secretory Phospholipase A2-IIa Is Involved in Prostate Cancer Progression and May Potentially Serve as a Biomarker for Prostate Cancer Carcinogenesis 2010, 31, 1948-1955
8. Kupert, E.; Anderson, M.; Liu, Y.; Succop, P.; Levin, L.; Wang, J.; Wikenheiser-brokamp, K.; Chen, P.; Pinney, S. M.; Macdonald, T. et al. Plasma Secretory Phospholipase A2-IIa as a Potential Biomarker for Lung Cancer in Patients with Solitary Pulmonary Nodules BMC Cancer 2011, 11, 513-522
9. Chemburu, S.; Ji, E.; Casana, Y.; Wu, Y.; Buranda, T.; Schanze, K. S.; Lopez, G. P.; Whitten, D. G. Conjugated Polyelectrolyte Supported Bead Based Assays for Phospholipase A2 Activity J. Phys. Chem. B 2008, 112, 14492-14499
10. Feng, L.; Manabe, K.; Shope, J. C.; Widmer, S.; DeWald, D. B.; Prestwich, G. D. A Real-Time Fluorogenic Phospholipase A2 Assay for Biochemical and Cellular Activity Measurements Chem. Biol. 2002, 9, 795-803
11. Okada, S. Y.; Jelinek, R.; Charych, D. Induced Color Change of Conjugated Polymeric Vesicles by Interfacial Catalysis of Phospholipase A2 Angew. Chem., Int. Ed. 1999, 38, 655-659
12. Dennis, E. A.; Cao, J.; Hsu, Y.-H.; Magrioti, V.; Kokotos, G. Phospholipase A2 Enzymes: Physical Structure, Biological Function, Disease Implication, Chemical Inhibition, and Therapeutic Intervention Chem. Rev. 2011, 111, 6130-6185
13. Lee, D.-S.; Jeon, B. G.; Ihm, C.; Park, J.-K.; Jung, M. Y. A Simple and Smart Telemedicine Device for Developing Regions: A Pocket-Sized Colorimetric Reader Lab Chip 2011, 11, 120-126
14. Martinez, A. W.; Phillips, S. T.; Carrilho, E.; Thomas, S. W., III; Sindi, H.; Whitesides, G. M. Simple Telemedicine for Developing Regions: Camera Phones and Paper-Based Microfluidic Devices for Real-Time, Off-Site Diagnosis Anal. Chem. 2008, 80, 3699-3707
15. Xiao, Z.; Lie, P.; Fang, Z.; Yu, L.; Chen, J.; Liu, J.; Ge, C.; Zhou, X.; Zeng, L. A Lateral Flow Biosensor for Detection of Single Nucleotide Polymorphism by Circular Strand Displacement Reaction Chem. Commun. 2012, 48, 8547-8549
16. Rohrman, B. A.; Leautaud, V.; Molyneux, E.; Richards-Kortum, R. R. A Lateral Flow Assay for Quantitative Detection of Amplified HIV-1 RNA PLoS One 2012, 7, e45611
17. Xu, H.; Mao, X.; Zeng, Q.; Wang, S.; Kawde, A.-N.; Liu, G. Aptamer-Functionalized Gold Nanoparticles as Probes in a Dry-Reagent Strip Biosensor for Protein Analysis Anal. Chem. 2009, 81, 669-675
18. Liu, G.; Mao, X.; Phillips, J. A.; Xu, H.; Tan, W.; Zeng, L. Aptamer-Nanoparticle Strip Biosensor for Sensitive Detection of Cancer Cells Anal. Chem. 2009, 81, 10013-10018
19. Mazumdar, D.; Liu, J.; Lu, G.; Zhou, J.; Lu, Y. Easy-to-Use Dipstick Tests for Detection of Lead in Paints Using Non-Cross-Linked Gold Nanoparticle-Dnazyme Conjugates Chem. Commun. 2010, 46, 1416-1418
20. Liu, J.; Mazumdar, D.; Lu, Y. A Simple and Sensitive "Dipstick" Test in Serum Based on Lateral Flow Separation of Aptamer-Linked Nanostructures Angew. Chem., Int. Ed. 2006, 45, 7955-7959
21. Saha, K.; Agasti, S. S.; Kim, C.; Li, X.; Rotello, V. M. Gold Nanoparticles in Chemical and Biological Sensing Chem. Rev. 2012, 112, 2739-2779
22. Howes, P. D.; Rana, S.; Stevens, M. M. Plasmonic Nanomaterials for Biodiagnostics Chem. Soc. Rev. 2014, 43, 3835-3853
23. Jans, H.; Huo, Q. Gold Nanoparticle-Enabled Biological and Chemical Detection and Analysis Chem. Soc. Rev. 2012, 41, 2849-2866
24. Jain, P. K.; Lee, K. S.; El-Sayed, I. H.; El-Sayed, M. A. Calculated Absorption and Scattering Properties of Gold Nanoparticles of Different Size, Shape, and Composition: Applications in Biological Imaging and Biomedicine J. Phys. Chem. B 2006, 110, 7238-7248
25. Laromaine, A.; Koh, L.; Murugesan, M.; Ulijn, R. V.; Stevens, M. M. Protease-Triggered Dispersion of Nanoparticle Assemblies J. Am. Chem. Soc. 2007, 129, 4156-4157
26. Elghanian, R.; Storhoff, J. J.; Mucic, R. C.; Letsinger, R. L.; Mirkin, C. A. Selective Colorimetric Detection of Polynucleotides Based on the Distance-Dependent Optical Properties of Gold Nanoparticles Science 1997, 277, 1078-1081
27. Du, J.; Jiang, L.; Shao, Q.; Liu, X.; Marks, R. S.; Ma, J.; Chen, X. Colorimetric Detection of Mercury Ions Based on Plasmonic Nanoparticles Small 2013, 9, 1467-1481
28. Aili, D.; Gryko, P.; Sepulveda, B.; Dick, J. A. G.; Kirby, N.; Heenan, R.; Baltzer, L.; Liedberg, B.; Ryan, M. P.; Stevens, M. M. Polypeptide Folding-Mediated Tuning of the Optical and Structural Properties of Gold Nanoparticle Assemblies Nano Lett. 2011, 11, 5564-5573
29. Aili, D.; Mager, M.; Roche, D.; Stevens, M. M. Hybrid Nanoparticle-Liposome Detection of Phospholipase Activity Nano Lett. 2011, 11, 1401-1405
30. Mammen, M.; Choi, S. K.; Whitesides, G. M. Polyvalent Interactions in Biological Systems: Implications for Design and Use of Multivalent Ligands and Inhibitors Angew. Chem., Int. Ed. 1998, 37, 2755-2794
31. Lim, Y.-b.; Lee, M. Self-Assembled Multivalent Carbohydrate Ligands Org. Biomol. Chem. 2007, 5, 401-405
32. Huskens, J. Multivalent Interactions at Interfaces Curr. Opin. Chem. Biol. 2006, 10, 537-543
33. Fasting, C.; Schalley, C. A.; Weber, M.; Seitz, O.; Hecht, S.; Koksch, B.; Dernedde, J.; Graf, C.; Knapp, E.-W.; Haag, R. Multivalency as a Chemical Organization and Action Principle Angew. Chem., Int. Ed. 2012, 51, 10472-10498
34. de la Rica, R.; Fratila, R. M.; Szarpak, A.; Huskens, J.; Velders, A. H. Multivalent Nanoparticle Networks as Ultrasensitive Enzyme Sensors Angew. Chem., Int. Ed. 2011, 50, 5703-5706
35. Marsh, D.; Bartucci, R.; Sportelli, L. Lipid Membranes with Grafted Polymers: Physicochemical Aspects Biochim. Biophys. Acta, Biomembr. 2003, 1615, 33-59
36. Li, H. Y.; Park, S. H.; Reif, J. H.; LaBean, T. H.; Yan, H. DNA-Templated Self-Assembly of Protein and Nanoparticle Linear Arrays J. Am. Chem. Soc. 2004, 126, 418-419
37. Chen, C.; Han, D.; Cai, C.; Tang, X. An Overview of Liposome Lyophilization and Its Future Potential J. Controlled Release 2010, 142, 299-311
38. Xu, W.; Yi, L.; Feng, Y.; Chen, L.; Liu, J. Structural Insight into the Activation Mechanism of Human Pancreatic Prophospholipase A2 J. Biol. Chem. 2009, 284, 16659-16666
39. Nevalainen, T. J.; Gronroos, J. M.; Kortesuo, P. T. Pancreatic and Synovial Type Phospholipases A2 in Serum Samples from Patients with Severe Acute Pancreatitis Gut 1993, 34, 1133-1136
40. Green, J. A.; Smith, G. M.; Buchta, R.; Lee, R.; Ho, K. Y.; Rajkovic, I. A.; Scott, K. F. Circulating Phospholipase A2 Activity Associated with Sepsis and Septic Shock Is Indistinguishable from That Associated with Rheumatoid Arthritis Inflammation 1991, 15, 355-367
41. Pruzanski, W.; Vadas, P.; Stefanski, E.; Urowitz, M. B. Phospholipase A2 Activity in Sera and Synovial Fluids in Rheumatoid Arthritis and Osteoarthritis. Its Possible Role as a Proinflammatory Enzyme J. Rheumatol. 1985, 12, 211-216
42. Koenig, W.; Vossen, C. Y.; Mallat, Z.; Brenner, H.; Benessiano, J.; Rothenbacher, D. Association between Type II Secretory Phospholipase A2 Plasma Concentrations and Activity and Cardiovascular Events in Patients with Coronary Heart Disease Eur. Heart. J. 2009, 30, 2742-2748
43. Dutour, A.; Achard, V.; Sell, H.; Naour, N.; Collart, F.; Gaborit, B.; Silaghi, A.; Eckel, J.; Alessi, M.-C.; Henegar, C. et al. Secretory Type II Phospholipase A2 Is Produced and Secreted by Epicardial Adipose Tissue and Overexpressed in Patients with Coronary Artery Disease J. Clin. Endocrinol. Metab. 2010, 95, 963-967
44. Schevitz, R. W.; Bach, N. J.; Carlson, D. G.; Chirgadze, N. Y.; Clawson, D. K.; Dillard, R. D.; Draheim, S. E.; Hartley, L. W.; Jones, N. D.; Mihelich, E. D. et al. Structure-Based Design of the First Potent and Selective Inhibitor of Human Non-Pancreatic Secretory Phospholipase A2 Nat. Struct. Biol. 1995, 2, 458-465